The maximum maintenance dose for each patient will be determined by their healthcare provider
Because this mechanism is glucose-dependent (only activated when blood glucose levels are elevated), DPP-4 inhibitors do not carry the risk of hypoglycemia, unlike traditional insulin secretagogues
Glucagon-like peptide-1 (GLP-1) receptor agonists were first developed in the 1990s to treat type 2 diabetes by stimulating insulin secretion in response to glucose
A practical target many clinicians recommend is roughly 20 to 30 grams of protein per meal as a simple rule of thumb to prevent big post-meal crashes, but tailor that with your provider or dietitian
The design is clean and modern, balancing simplicity with sophistication
Onceweekly albiglutide versus oncedaily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, openlabel, multicentre, noninferiority phase 3 study